EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking Mediated Virtual Drug Screening for GABAA Receptor: Promising Digoxin Derivatives

Hüseyin Saygın PORTAKAL

Hacettepe Journal of Biology and Chemistry · 2023

DOI: 10.15671/hjbc.1139995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hacettepe Journal of Biology and Chemistry, 2023. Verfasst von Hüseyin Saygın PORTAKAL. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the central nervous system (CNS) of mammalian species, ℽ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter due to it regulates neuronal development through leading neural differentiation, proliferation, migration, etc. GABAA receptor is the major GABA receptor since it has the highest expression level among the other GABA receptors within CNS. Many pieces of evidence prove that the defects in the GABAergic pathway might give rise to serious diseases such as schizophrenia, epilepsy, anxiety, depression, insomnia, etc. In this study drug library with a totally of 8170 ligands consists of three distinct datasets which are FDA-approved Drugs, Drugs Approved by World but not FDA, and Non-human Metabolites have been screened for the allosteric site of the GABAA receptor with PyRx Virtual Screening Tool and ligand-receptor interactions have been analyzed with Biovia Discovery Studio software. Results reveal that Digoxin and its two distinct derivatives (DD1 and DD2), as well as Conivaptan, are promising in the treatment of GABAergic pathway-based disorders. The findings of this report should be verified with further molecular dynamics (MD) simulations and the ligands should be tested by both in vitro and in vivo studies.

Zitieren

APA

PORTAKAL, H. S. (2023). Molecular Docking Mediated Virtual Drug Screening for GABAA Receptor: Promising Digoxin Derivatives. Hacettepe Journal of Biology and Chemistry. https://doi.org/10.15671/hjbc.1139995

Vancouver

PORTAKAL HS. Molecular Docking Mediated Virtual Drug Screening for GABAA Receptor: Promising Digoxin Derivatives. Hacettepe Journal of Biology and Chemistry. 2023. doi:10.15671/hjbc.1139995

BibTeX
@article{PORTAKAL2023,
  author = {PORTAKAL, Hüseyin Saygın},
  title = {Molecular Docking Mediated Virtual Drug Screening for GABAA Receptor: Promising Digoxin Derivatives},
  journal = {Hacettepe Journal of Biology and Chemistry},
  year = {2023},
  doi = {10.15671/hjbc.1139995}
}
Kostenlos starten →